c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
OSTX
OS Therapies Incorporated
stock
NYSEAMERICAN
Market Open
Nov 18, 2026 10:17:05 AM EST
0.87
USD
+16.823%
(+0.13)
242,347
Pre-market
After-hours
0.7000
Bid
0.9700
Ask
0.2700
Spread
Overview
Company
Exchanges
Shorts
News
News
OSTX News
1
/
1
Nov 5, 2026
Day breaks
Nov 13, 2026
08:30 AM EST
OS Therapies Announces Shelving of U.S. FDA Commissioner's National Priority Voucher Has No Impact on the Company
·
Newsfile
Nov 12, 2026
01:22 PM EST
OS Therapies receives VAT refund and FDA updates on voucher programs
·
Investing.com
Nov 10, 2026
08:15 AM EST
OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma
·
Newsfile
Nov 5, 2026
08:00 AM EST
OS Therapies Completes Requalification of Phase 2b Herlystic (OST-HER2) Drug Substance for Confirmatory Phase 3 Trial
·
Newsfile
Oct 19, 2026
08:30 AM EDT
OS Therapies Announces Initial Closing of Warrant Exercise Inducement and Exchange Offer for Initial Gross Proceeds of Approximately $7.2 Million
·
Newsfile
Oct 7, 2026
08:30 AM EDT
OS Animal Health Receives USDA Feedback on Regulatory Pathway for OST-HER2 in Canine Osteosarcoma
·
Newsfile
Oct 6, 2026
08:30 AM EDT
OS Therapies Achieves Statistically Significant Final Three-Year Overall Survival Benefit for Herlystic(TM)-Treated Patients in Phase 2b Pulmonary Metastatic Osteosarcoma Trial
·
Newsfile
Oct 1, 2026
09:01 AM EDT
OS Therapies appoints Kerry Clem as CCO, Frank Knuettel II as CFO
·
Seeking Alpha
08:30 AM EDT
OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer
·
Newsfile
Sep 24, 2026
08:22 AM EDT
OS Therapies Announces Brand Name 'Herlystic' Approved by World Health Organization for OST-HER2 (daznelimgene lisbac)
·
Newsfile
Sep 21, 2026
06:30 AM EDT
OS Therapies Completes FDA Type C Statistical Methods Meeting and Provides Update on Global Regulatory Coordination for OST-HER2 Under Project Orbis
·
Newsfile